Alumis scientific chief Goldstein sells 629 shares

Q: How many ALMS shares did David M. Goldstein sell and at what price?

David M. Goldstein sold 629 shares on November 2, 2026, at a weighted average sale price of $6.52 per share. The reported sale prices ranged from $6.41 to $6.52 per share.

Q: Why did David M. Goldstein sell ALMS shares?

The 629-share sale was effected under the issuer’s policy requiring sell-to-cover to satisfy tax obligations incurred with the vesting and settlement of restricted stock units granted July 29, 2025. The transaction was not discretionary.

The sale was required under Alumis Inc.'s policy to cover tax obligations tied to restricted stock unit vesting and settlement.

Available on EDGAR 11/04/2026 - 04:35 PM EST Accepted by SEC EDGAR 11/04/2026 - 04:35 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Alumis Inc. Chief Scientific Officer David M. Goldstein sold 629 shares of common stock on November 2, 2026, at a weighted average sale price of $6.52 per share; the reported sale prices ranged from $6.41 to $6.52 per share. The sale was effected under the issuer’s policy requiring sell-to-cover for tax obligations from vesting and settlement of restricted stock units granted July 29, 2025, and was not discretionary. After the sale, Goldstein directly held 30,341 shares. Separately, 208,237 shares were held by the Baily Goldstein Living Trust, for which he is trustee, and 8,994 shares were held by family members residing at his primary residence.

Insider Trade Summary

Net Seller: 629 shares

Net Sell 1 txn

Insider Goldstein David M

Role Chief Scientific Officer

Sold 629 shs ($4K)

Share of Position Sold 2.0%

Type	Security	Shares	Price	Value
Sale	Common Stock ^{F1, F2}	629	$6.52	$4K
Holding	Common Stock ^F3	--	--	--
Holding	Common Stock ^F4	--	--	--

Holdings After Transaction: Common Stock — 30,341 shares (Direct); Common Stock — 208,237 shares (Indirect, By Trust); Common Stock — 8,994 shares (Indirect, By Family Members)

Holdings Before and After: Common Stock, 30,970 to 30,341 shares (Direct)

Other Insiders: 5 other insiders reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (4)

F1. The sale reported on this Form 4 was effected pursuant to the Issuer's policy requiring sell-to-cover to satisfy tax obligations of the Reporting Person incurred with the vesting and settlement of restricted stock units granted on July 29, 2025, and does not represent a discretionary sale by the Reporting Person.
F2. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $6.41 to $6.52 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3. Shares are held directly by the Baily Goldstein Living Trust dated March 4, 2014, for which the Reporting Person serves as a trustee.
F4. Shares are held directly by family members of Reporting Person residing in his primary residence.

Key Figures

Common shares sold: 629 shares Weighted average sale price: $6.52 per share Reported sale price range: $6.41–$6.52 per share +3 more

6 metrics

Common shares sold 629 shares Sale on November 2, 2026

Weighted average sale price $6.52 per share Sale on November 2, 2026

Reported sale price range $6.41–$6.52 per share Prices across multiple transactions

Direct shares held after sale 30,341 shares Reported after the November 2, 2026 sale

Shares held by Baily Goldstein Living Trust 208,237 shares Reported on November 2, 2026

Shares held by family members 8,994 shares Reported on November 2, 2026

Key Terms

sell-to-cover, restricted stock units, weighted average sale price

3 terms

sell-to-cover financial

"policy requiring sell-to-cover to satisfy tax obligations"

Sell-to-cover is when part of newly issued or exercised company stock is immediately sold to pay required taxes and fees, so the recipient keeps the remaining shares. For investors this matters because it reduces the number of shares insiders or employees actually hold after a grant, can create small, routine share sales that aren’t signal of cashing out, and slightly increases share supply on the market—like selling a portion of a paycheck to cover the tax bill.

restricted stock units financial

"vesting and settlement of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

weighted average sale price financial

"reported price ... is a weighted average sale price"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ALMS shares did David M. Goldstein sell and at what price?

David M. Goldstein sold 629 shares on November 2, 2026, at a weighted average sale price of $6.52 per share. The reported sale prices ranged from $6.41 to $6.52 per share.

Why did David M. Goldstein sell ALMS shares?

The 629-share sale was effected under the issuer’s policy requiring sell-to-cover to satisfy tax obligations incurred with the vesting and settlement of restricted stock units granted July 29, 2025. The transaction was not discretionary.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Goldstein David M

(Last)

(First)

(Middle)

C/O ALUMIS INC.

280 EAST GRAND AVENUE

(Street)

SOUTH SAN FRANCISCO

CALIFORNIA

94080

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ALUMIS INC. [ ALMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Scientific Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	11/02/2026		S		629⁽¹⁾	D	$6.52⁽²⁾	30,341	D
Common Stock								208,237	I	By Trust⁽³⁾
Common Stock								8,994	I	By Family Members⁽⁴⁾

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The sale reported on this Form 4 was effected pursuant to the Issuer's policy requiring sell-to-cover to satisfy tax obligations of the Reporting Person incurred with the vesting and settlement of restricted stock units granted on July 29, 2025, and does not represent a discretionary sale by the Reporting Person.

2. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $6.41 to $6.52 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. Shares are held directly by the Baily Goldstein Living Trust dated March 4, 2014, for which the Reporting Person serves as a trustee.

4. Shares are held directly by family members of Reporting Person residing in his primary residence.

	/s/ Sanam Pangali, Attorney-in-Fact	11/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR